+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Capecitabine Market Report 2025 - Product Thumbnail Image

Capecitabine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bevacizumab Biosimilars Market Report 2025 - Product Thumbnail Image

Bevacizumab Biosimilars Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Remicade Biosimilar Market Report 2025 - Product Thumbnail Image

Remicade Biosimilar Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
AVASTIN Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AVASTIN Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Gouty Arthritis (Gout) - Pipeline Insight, 2024 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator